Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance
Open Access
- 18 June 2025
- journal article
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 6 (1) , 58-72
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War (W81XWH-21\u20131\u20130267)
- U.S. Department of War (W81XWH-19\u20131\u20130777)
- National Cancer Institute (U54CA156734)
- National Cancer Institute (R01CA282906)
- National Cancer Institute (R01CA299202)
- University of Massachusetts Boston
- National Institutes of Health
This publication has 232 references indexed in Scilit:
- FOXA1 regulates ribosomal RNA transcription in prostate cancerThe Prostate, 2024
- Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trialAnnals of Oncology, 2023
- Androgen receptor splice variant 7 functions independently of the full length receptor in prostate cancer cellsCancer Letters, 2021
- Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancerMolecular Oncology, 2021
- Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer modelsInternational Journal of Cancer, 2019
- Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancerCancer Letters, 2018
- Tyrosine Phosphorylation of the Pioneer Transcription Factor FoxA1 Promotes Activation of Estrogen SignalingJournal of Cellular Biochemistry, 2016
- N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerCancer Cell, 2016
- Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cellsThe International Journal of Biochemistry & Cell Biology, 2014
- Androgen receptor: A key molecule in the progression of prostate cancer to hormone independenceJournal of Cellular Biochemistry, 2003